End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study.
Advanced fibrosing interstitial lung disease (ILD) is often progressive and associated with a high burden of symptoms and poor prognosis. Little is known about the symptom prevalence and access to palliative care services at end of life (EOL).
